Brain HealthSemaglutide Reshapes Brain Reward Circuits Even in Healthy Subjects
Semaglutide, the GLP-1 receptor agonist behind Ozempic and Wegovy, is known for its metabolic benefits, but its effects on healthy brains are poorly understood. Researchers at Aarhus University gave healthy mice daily semaglutide injections and observed measurable changes in behaviors linked to stress and reward-seeking. Separately, a single acute dose altered oscillatory brain activity in the nucleus accumbens — the brain's reward hub — across delta, theta, and alpha frequency bands. These findings matter because millions of people without metabolic disease may eventually use GLP-1 drugs for longevity or other purposes. Understanding how semaglutide changes brain dynamics in healthy individuals is essential for evaluating its full risk-benefit profile beyond weight loss and diabetes management.
